Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Science to Consumers's Total Liabilities for the quarter that ended in Feb. 2017 was $0.09 Mil. Science to Consumers's Total Assets for the quarter that ended in Feb. 2017 was $0.01 Mil.
Therefore, Science to Consumers's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2017 was 14.33.
Science to Consumers (OTCPK:BEUT) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Science to Consumers Liabilities-to-Assets Related Terms
Science to Consumers Liabilities-to-Assets Historical Data
* Premium members only.
The historical data trend for Science to Consumers's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BEUT vs CAWW, TECR: Liabilities-to-Assets Comparison
For the Household & Personal Products subindustry, Science to Consumers's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Science to Consumers Liabilities-to-Assets vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Science to Consumers's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Science to Consumers's Liabilities-to-Assets falls into.
Science to Consumers Liabilities-to-Assets Calculation
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Science to Consumers's Liabilities-to-Assets Ratio for the fiscal year that ended in May. 2016 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Science to Consumers (BEUT) has a Liabilities-to-Assets of 14.33 as of Feb. 2017. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Science to Consumers and its competitors.
Is Science to Consumers' Liabilities-to-Assets too high?
Science to Consumers' current Liabilities-to-Assets is 14.33.
How does Science to Consumers' Liabilities-to-Assets compare to CAWW and TECR?
Science to Consumers' Liabilities-to-Assets of 14.33 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Consumer Packaged Goods company?
A good Liabilities-to-Assets depends on the Consumer Packaged Goods industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Science to Consumers and its competitors. Science to Consumers's current Liabilities-to-Assets is 14.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Science to Consumers stock overvalued right now?
Science to Consumers (BEUT) has a current Liabilities-to-Assets of 14.33. The current Liabilities-to-Assets is 14.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Science to Consumers (BEUT), the current Liabilities-to-Assets is 14.33 as of Feb. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Science to Consumers Inc is engaged in the development of anti-aging products. Its products include Dermalastyl Facial Scrub, Dermalastyl Bx Pro, Dermalastyl Bx Elastropin, Dermalastyl-e Intensive Eye Serum, Dermalastyl-m Wrinkle Eye Radicator, Dermalastyl-m Anti- Wrinkle after-shave for Men. The company provides direct-to-consumer sales, marketing and distribution of finished consumer skin care products provided by Protein Genomics via direct response advertisements and other globally marketing and distribution channels.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BEUT has been successfully added to your 
